Loading organizations...
§ Venture Capital
Venture capital firm investing in early-stage medical device and biotechnology companies, focused on healthcare technologies.
Esquilime Partners is a venture capital firm of undisclosed location that provides equity financing to early-stage medical device and biotechnology companies. The organization focuses on supporting innovative healthcare technologies, specifically targeting clinical advancements in spinal and orthopedic instrumentation. As part of its core investment strategy, the firm allocates capital to specialized life sciences enterprises such as Paradigm BioDevices. In executing these healthcare transactions, Esquilime Partners has participated in syndicated funding rounds alongside established institutional investors including DeNovo Ventures, Domain Associates, InterWest Partners, and Technology Partners. While specific financial metrics regarding the firm's total assets under management, active portfolio size, and employee count remain undisclosed, its investment activity was notably documented during the winter of 2016. The firm's exact founding year and the identities of its original founders are not currently available in public financial records.
Esquilime Partners has 1 tracked investment across 1 company. The latest tracked deal is $60.0M Debt / Other Equity in Benvenue Medical in January 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 6, 2016 | Benvenue Medical | $60.0M Debt / Other Equity | — | CRG, DeNovo Ventures, Domain Associates, Interwest Partners, Technology Partners, DON Milder |